Logo image of LXU

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

NYSE:LXU - US5021601043 - Common Stock

8.42 USD
+0.15 (+1.81%)
Last: 8/28/2025, 8:23:50 PM
8.42 USD
0 (0%)
After Hours: 8/28/2025, 8:23:50 PM
Fundamental Rating

3

Overall LXU gets a fundamental rating of 3 out of 10. We evaluated LXU against 84 industry peers in the Chemicals industry. The financial health of LXU is average, but there are quite some concerns on its profitability. LXU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LXU had positive earnings in the past year.
In the past year LXU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LXU reported negative net income in multiple years.
LXU had a positive operating cash flow in 4 of the past 5 years.
LXU Yearly Net Income VS EBIT VS OCF VS FCFLXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

LXU has a Return On Assets of -2.94%. This is in the lower half of the industry: LXU underperforms 66.67% of its industry peers.
With a Return On Equity value of -6.69%, LXU is not doing good in the industry: 65.48% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.94%
ROE -6.69%
ROIC N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
LXU Yearly ROA, ROE, ROICLXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

LXU's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 7.11%, LXU is doing worse than 88.10% of the companies in the same industry.
LXU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LXU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.11%
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
LXU Yearly Profit, Operating, Gross MarginsLXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
LXU has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LXU has more shares outstanding
The debt/assets ratio for LXU has been reduced compared to a year ago.
LXU Yearly Shares OutstandingLXU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXU Yearly Total Debt VS Total AssetsLXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

LXU has an Altman-Z score of 1.48. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.48, LXU is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.91 indicates that LXU is somewhat dependend on debt financing.
LXU has a Debt to Equity ratio of 0.91. This is in the lower half of the industry: LXU underperforms 63.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACCN/A
WACC8.91%
LXU Yearly LT Debt VS Equity VS FCFLXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

A Current Ratio of 2.64 indicates that LXU has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.64, LXU is doing good in the industry, outperforming 71.43% of the companies in the same industry.
A Quick Ratio of 2.05 indicates that LXU has no problem at all paying its short term obligations.
The Quick ratio of LXU (2.05) is better than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.05
LXU Yearly Current Assets VS Current LiabilitesLXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

LXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.24%, which is quite good.
LXU shows a small growth in Revenue. In the last year, the Revenue has grown by 2.60%.
The Revenue has been growing slightly by 7.43% on average over the past years.
EPS 1Y (TTM)17.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%8.01%

3.2 Future

LXU is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.59% yearly.
The Revenue is expected to grow by 3.95% on average over the next years.
EPS Next Y-19.74%
EPS Next 2Y-17.21%
EPS Next 3Y2.38%
EPS Next 5Y1.59%
Revenue Next Year14.66%
Revenue Next 2Y7.06%
Revenue Next 3Y6.11%
Revenue Next 5Y3.95%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LXU Yearly Revenue VS EstimatesLXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LXU Yearly EPS VS EstimatesLXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.76, the valuation of LXU can be described as rather expensive.
LXU's Price/Earnings ratio is in line with the industry average.
LXU is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 21.94, the valuation of LXU can be described as rather expensive.
LXU's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of LXU to the average of the S&P500 Index (22.78), we can say LXU is valued inline with the index average.
Industry RankSector Rank
PE 24.76
Fwd PE 21.94
LXU Price Earnings VS Forward Price EarningsLXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

LXU's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.39
LXU Per share dataLXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.21%
EPS Next 3Y2.38%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LXU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LSB INDUSTRIES INC

NYSE:LXU (8/28/2025, 8:23:50 PM)

After market: 8.42 0 (0%)

8.42

+0.15 (+1.81%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners54.36%
Inst Owner Change4.09%
Ins Owners4.21%
Ins Owner Change0.29%
Market Cap605.73M
Analysts75
Price Target8.99 (6.77%)
Short Float %3.84%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.88%
Min EPS beat(2)-33.99%
Max EPS beat(2)69.76%
EPS beat(4)3
Avg EPS beat(4)67.73%
Min EPS beat(4)-33.99%
Max EPS beat(4)135.15%
EPS beat(8)5
Avg EPS beat(8)38.25%
EPS beat(12)7
Avg EPS beat(12)19.05%
EPS beat(16)10
Avg EPS beat(16)40.13%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-4.79%
Max Revenue beat(2)6.25%
Revenue beat(4)3
Avg Revenue beat(4)6.96%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)13.55%
Revenue beat(8)6
Avg Revenue beat(8)4.28%
Revenue beat(12)9
Avg Revenue beat(12)4.2%
Revenue beat(16)11
Avg Revenue beat(16)3.01%
PT rev (1m)7.14%
PT rev (3m)2.71%
EPS NQ rev (1m)185.71%
EPS NQ rev (3m)335.29%
EPS NY rev (1m)34.85%
EPS NY rev (3m)85.42%
Revenue NQ rev (1m)3.93%
Revenue NQ rev (3m)41.66%
Revenue NY rev (1m)4.21%
Revenue NY rev (3m)2.39%
Valuation
Industry RankSector Rank
PE 24.76
Fwd PE 21.94
P/S 1.12
P/FCF N/A
P/OCF 13.14
P/B 1.22
P/tB 1.22
EV/EBITDA 10.39
EPS(TTM)0.34
EY4.04%
EPS(NY)0.38
Fwd EY4.56%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.64
OCFY7.61%
SpS7.49
BVpS6.89
TBVpS6.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.94%
ROE -6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.11%
FCFM N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.64%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA 5.75
Cap/Depr 124.63%
Cap/Sales 18.3%
Interest Coverage N/A
Cash Conversion 58.81%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.05
Altman-Z 1.48
F-Score4
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)96.58%
Cap/Depr(5y)76.59%
Cap/Sales(3y)11.38%
Cap/Sales(5y)9.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
EPS Next Y-19.74%
EPS Next 2Y-17.21%
EPS Next 3Y2.38%
EPS Next 5Y1.59%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%8.01%
Revenue Next Year14.66%
Revenue Next 2Y7.06%
Revenue Next 3Y6.11%
Revenue Next 5Y3.95%
EBIT growth 1Y-103.81%
EBIT growth 3Y-60.57%
EBIT growth 5YN/A
EBIT Next Year2179.64%
EBIT Next 3Y189.92%
EBIT Next 5Y92.67%
FCF growth 1Y-131.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.77%
OCF growth 3Y-0.4%
OCF growth 5Y110.4%